CMS Proposed Model Test Would Lower Certain Medicare Part B Prescription Drugs

Centers for Medicare & Medicaid Services

CMS Proposed Model Test Would Lower Certain Medicare Part B Prescription Drugs

What’s new: CMS announces the newly proposed GLOBE (Global Benchmark for Efficient Drug Pricing) Model that would lower costs of drugs covered by Medicare Part B.

Why it matters: GLOBE would help make critical medications more accessible for people with Medicare, better enabling them to follow their prescribed care for optimal health outcomes, and alleviating financial strain on Medicare and for American taxpayers.

What to expect: CMS is seeking public comment on GLOBE through an NPRM, which is available on the Federal Register.

The big picture: This proposed drug model advances the Innovation Center’s commitment to help people with Medicare live healthier lives and promote the sustainability of the Medicare program through more affordable medications; it is part of the Trump Administration’s groundbreaking strategy to tackle rising drug costs for Americans.

Find out more:

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS).

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS).

This email was sent to NP7epxb8a@niepodam.pl using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244